| Code | CSB-RA011626MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to reference antibody 9MW1911, targeting IL1RL1 (Interleukin 1 Receptor Like 1), also known as ST2. IL1RL1 functions as a receptor for IL-33 and plays a critical role in type 2 immune responses, mediating inflammatory and allergic reactions. Upon IL-33 binding, IL1RL1 activates intracellular signaling cascades that promote Th2 cell differentiation and cytokine production. This pathway is implicated in various pathological conditions including asthma, allergic diseases, cardiovascular disorders, and fibrotic diseases. Elevated soluble ST2 levels serve as biomarkers for heart failure and other inflammatory conditions.
As a biosimilar to 9MW1911, this antibody provides researchers with a reliable tool for investigating IL1RL1/ST2-mediated signaling pathways and its role in immune regulation. It supports studies examining the IL-33/ST2 axis in disease models and facilitates research into therapeutic strategies targeting this pathway. This antibody is suitable for various experimental approaches aimed at understanding IL1RL1 biology and its contribution to inflammatory and cardiovascular pathophysiology.
There are currently no reviews for this product.